Considering that Pirfenidone is metabolised from the CYP1A2 enzyme pathway, any drug which inhibits this enzyme is probably going to precipitate the toxicity of pirfenidone: concomitant therapy would be to be prevented. lonapegsomatropin will decrease the extent or influence of pirfenidone by impacting hepatic enzyme CYP1A2 metabolism. The answer on https://cashqxcfh.dm-blog.com/29795890/rumored-buzz-on-azd3965